Chih Ming Chen
Algemeen Directeur bij TWI PHARMACEUTICALS INC
Actieve functies van Chih Ming Chen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TWI PHARMACEUTICALS INC | Algemeen Directeur | 01-12-1997 | - |
Voorzitter | 05-01-2004 | - | |
Oprichter | 01-12-1997 | - | |
Public Communications Contact | 01-12-1997 | - | |
President | 01-12-1997 | - | |
TWi Pharmaceuticals Holding, Inc.
TWi Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals Holding, Inc. provides pharmaceutical services. | Directeur/Bestuurslid | - | - |
Delightful Cheers Ltd. | Directeur/Bestuurslid | - | - |
Eldridge Capital Group Ltd. | Directeur/Bestuurslid | - | - |
Allgenesis Biotherapeutics, Inc.
Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Voorzitter | - | - |
Oprichter | - | - |
Loopbaan van Chih Ming Chen
Eerdere bekende functies van Chih Ming Chen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Jiachen International Pharmaceutical Co., Ltd.
Jiachen International Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiachen International Pharmaceutical Co., Ltd. engages in the investment, biotechnology service and management consulting industries. The company was founded on February 15, 2019 and is headquartered in Taipei, Taiwan. | Voorzitter | - | - |
TWI BIOTECHNOLOGY, INC. | Voorzitter | - | - |
Oprichter | 16-07-2010 | - |
Opleiding van Chih Ming Chen
The Ohio State University | Doctorate Degree |
National Taiwan University | Undergraduate Degree |
Statistieken
Internationaal
Taiwan | 7 |
Verenigde Staten | 3 |
Kaaimaneilanden | 2 |
Operationeel
Chairman | 4 |
Founder | 3 |
Director/Board Member | 3 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TWI BIOTECHNOLOGY, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
TWi Pharmaceuticals Holding, Inc.
TWi Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals Holding, Inc. provides pharmaceutical services. | Health Technology |
Delightful Cheers Ltd. | |
Eldridge Capital Group Ltd. | |
Jiachen International Pharmaceutical Co., Ltd.
Jiachen International Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiachen International Pharmaceutical Co., Ltd. engages in the investment, biotechnology service and management consulting industries. The company was founded on February 15, 2019 and is headquartered in Taipei, Taiwan. | Health Technology |
Allgenesis Biotherapeutics, Inc.
Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Health Technology |
- Beurs
- Insiders
- Chih Ming Chen
- Ervaring